Used as a key intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the development of analogs with enhanced analgesic and anti-inflammatory properties. Its structure supports the design of compounds that target cyclooxygenase (COX) enzymes, helping reduce inflammation and pain. The chlorobenzoyl and thiophene moieties contribute to improved metabolic stability and receptor binding affinity. It is also employed in medicinal chemistry research for developing new cyclopentane-fused heterocyclic systems with potential biological activity.